All you need to know about: Amyotrophic lateral sclerosis

Learn about Amyotrophic Lateral Sclerosis (ALS), its symptoms, risk factors, diagnosis, and current research advancements.

Q&A: New diagnostics and treatments for ALS and dementia—a key protein may point the way

The two neurodegenerative diseases could not appear more different. Amyotrophic lateral sclerosis (ALS), sometimes called Lou ...
ALS News Today

New research grants target ALS causes, biomarkers, gene therapy

The 2025 Research Innovation Grants are supporting projects focused on biomarkers, risk factors, and treatments for ALS.
ALS News Today

Aperture to advance potential treatment for ALS and dementia

Aperture will advance APRTX-001 as a potential treatment for ALS and frontotemporal dementia, with possible expansion for use ...
Stars and Stripes

Bill seeks to learn why veterans are at greater risk of developing fatal disease ALS than people with no military service

The Veterans With ALS Reporting Act seeks to develop strategies for lowering the potential risks for ALS, commonly known as ...
TipRanks on MSN

Tiziana Life Sciences’ Nasal Foralumab Trial Joins ALS MyMatch Program

An announcement from Tiziana Life Sciences ( ($TLSA) ) is now available. On November 25, 2025, Tiziana Life Sciences announced that its Phase 2 ...

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

Foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) currently in clinical development. Immunomodulation by intranasal foralumab represents a novel avenue for the treatment of ...

Health Rounds: Researchers find clue to potentially reversing ALS in lab studies

A specific RNA molecule can halt and reverse the nerve cell damage of amyotrophic lateral sclerosis, a study in mice suggests, a discovery that may pave the way for effective future treatments for the ...